ANI Pharmaceuticals, Inc. (ANIP) Revenue & EPS Growth Rates 2026

Growth Analysis - ANIP

Financial Metrics

Revenue Trends

Period:

CAGR Performance

Revenue

1Y Growth43.78%

5Y CAGR33.48%

10Y CAGR27.75%

Net Income

1Y GrowthN/A

5Y CAGRN/A

10Y CAGR17.68%

EPS

1Y GrowthN/A

5Y CAGRN/A

10Y CAGR10.08%

EBIT

1Y GrowthN/A

5Y CAGRN/A

10Y CAGR13.48%

EBITDA

1Y Growth161.88%

5Y CAGR48.12%

10Y CAGR17.99%

Capex

1Y Growth102.45%

5Y CAGR-12.86%

10Y CAGR0.49%

Equity

1Y Growth26.18%

5Y CAGR22.54%

10Y CAGR12.94%

Cash Flow

1Y Growth189.34%

5Y CAGR64.74%

10Y CAGR26.78%

Historical CAGR

Year	1Y CAGR	2Y CAGR	3Y CAGR	5Y CAGR	10Y CAGR	15Y CAGR	20Y CAGR	30Y CAGR
FY 2025 Dec 31, 2025	43.8%	34.7%	40.8%	33.5%	27.7%	48.0%	50.2%	N/A
FY 2024 Dec 31, 2024	26.2%	39.4%	41.7%	24.4%	27.1%	51.1%	56.6%	N/A
FY 2023 Dec 31, 2023	53.9%	50.1%	32.7%	19.3%	32.1%	38.2%	56.2%	N/A
FY 2022 Dec 31, 2022	46.4%	23.2%	15.3%	12.3%	63.6%	53.9%	26.6%	N/A
FY 2021 Dec 31, 2021	3.7%	2.3%	2.4%	10.9%	86.0%	19.8%	27.2%	N/A
FY 2020 Dec 31, 2020	0.9%	1.7%	5.6%	22.3%	55.8%	56.2%	N/A	N/A
FY 2019 Dec 31, 2019	2.5%	8.1%	17.1%	29.8%	66.5%	69.1%	N/A	N/A
FY 2018 Dec 31, 2018	14.0%	25.2%	38.2%	46.3%	48.8%	70.8%	44.8%	N/A
FY 2017 Dec 31, 2017	37.5%	52.2%	46.7%	138.3%	80.1%	31.7%	N/A	N/A
FY 2016 Dec 31, 2016	68.5%	51.6%	62.3%	212.0%	24.4%	33.2%	N/A	N/A
FY 2015 Dec 31, 2015	36.4%	59.3%	221.3%	98.5%	76.6%	N/A	N/A	N/A
FY 2014 Dec 31, 2014	86.1%	393.2%	404.8%	113.6%	93.0%	N/A	N/A	N/A
FY 2013 Dec 31, 2013	1207.5%	731.4%	129.9%	51.4%	84.6%	44.3%	N/A	N/A
FY 2012 Dec 31, 2012	428.7%	-3.6%	22.3%	36.1%	-2.1%	N/A	N/A	N/A
FY 2011 Dec 31, 2011	-82.4%	-41.2%	-51.4%	-50.4%	-13.0%	N/A	N/A	N/A
FY 2010 Dec 31, 2010	96.7%	-19.1%	71.2%	57.1%	N/A	N/A	N/A	N/A
FY 2009 Dec 31, 2009	-66.7%	59.7%	-55.7%	74.4%	N/A	N/A	N/A	N/A
FY 2008 Dec 31, 2008	666.8%	-48.8%	144.6%	125.0%	40.8%	N/A	N/A	N/A
FY 2007 Dec 31, 2007	-96.6%	38.1%	85.0%	-29.5%	N/A	N/A	N/A	N/A
FY 2006 Dec 31, 2006	5488.8%	1261.5%	504.1%	52.6%	N/A	N/A	N/A	N/A
FY 2005 Dec 31, 2005	231.7%	98.6%	-55.0%	N/A	N/A	N/A	N/A	N/A
FY 2004 Dec 31, 2004	18.9%	-83.4%	-64.5%	N/A	N/A	N/A	N/A	N/A
FY 2003 Dec 31, 2003	-97.7%	-80.6%	N/A	-11.9%	N/A	N/A	N/A	N/A
FY 2002 Dec 31, 2002	62.2%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2001 Dec 31, 2001	N/A	N/A	142.2%	N/A	N/A	N/A	N/A	N/A
FY 2000 Dec 31, 2000	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 1999 Dec 31, 1999	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 1998 Dec 31, 1998	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Growth Analysis - ANIP

Financial Metrics

Revenue Trends

Period:

CAGR Performance

Revenue

1Y Growth43.78%

5Y CAGR33.48%

10Y CAGR27.75%

Net Income

1Y GrowthN/A

5Y CAGRN/A

10Y CAGR17.68%

EPS

1Y GrowthN/A

5Y CAGRN/A

10Y CAGR10.08%

EBIT

1Y GrowthN/A

5Y CAGRN/A

10Y CAGR13.48%

EBITDA

1Y Growth161.88%

5Y CAGR48.12%

10Y CAGR17.99%

Capex

1Y Growth102.45%

5Y CAGR-12.86%

10Y CAGR0.49%

Equity

1Y Growth26.18%

5Y CAGR22.54%

10Y CAGR12.94%

Cash Flow

1Y Growth189.34%

5Y CAGR64.74%

10Y CAGR26.78%

Historical CAGR

Year	1Y CAGR	2Y CAGR	3Y CAGR	5Y CAGR	10Y CAGR	15Y CAGR	20Y CAGR	30Y CAGR
FY 2025 Dec 31, 2025	43.8%	34.7%	40.8%	33.5%	27.7%	48.0%	50.2%	N/A
FY 2024 Dec 31, 2024	26.2%	39.4%	41.7%	24.4%	27.1%	51.1%	56.6%	N/A
FY 2023 Dec 31, 2023	53.9%	50.1%	32.7%	19.3%	32.1%	38.2%	56.2%	N/A
FY 2022 Dec 31, 2022	46.4%	23.2%	15.3%	12.3%	63.6%	53.9%	26.6%	N/A
FY 2021 Dec 31, 2021	3.7%	2.3%	2.4%	10.9%	86.0%	19.8%	27.2%	N/A
FY 2020 Dec 31, 2020	0.9%	1.7%	5.6%	22.3%	55.8%	56.2%	N/A	N/A
FY 2019 Dec 31, 2019	2.5%	8.1%	17.1%	29.8%	66.5%	69.1%	N/A	N/A
FY 2018 Dec 31, 2018	14.0%	25.2%	38.2%	46.3%	48.8%	70.8%	44.8%	N/A
FY 2017 Dec 31, 2017	37.5%	52.2%	46.7%	138.3%	80.1%	31.7%	N/A	N/A
FY 2016 Dec 31, 2016	68.5%	51.6%	62.3%	212.0%	24.4%	33.2%	N/A	N/A
FY 2015 Dec 31, 2015	36.4%	59.3%	221.3%	98.5%	76.6%	N/A	N/A	N/A
FY 2014 Dec 31, 2014	86.1%	393.2%	404.8%	113.6%	93.0%	N/A	N/A	N/A
FY 2013 Dec 31, 2013	1207.5%	731.4%	129.9%	51.4%	84.6%	44.3%	N/A	N/A
FY 2012 Dec 31, 2012	428.7%	-3.6%	22.3%	36.1%	-2.1%	N/A	N/A	N/A
FY 2011 Dec 31, 2011	-82.4%	-41.2%	-51.4%	-50.4%	-13.0%	N/A	N/A	N/A
FY 2010 Dec 31, 2010	96.7%	-19.1%	71.2%	57.1%	N/A	N/A	N/A	N/A
FY 2009 Dec 31, 2009	-66.7%	59.7%	-55.7%	74.4%	N/A	N/A	N/A	N/A
FY 2008 Dec 31, 2008	666.8%	-48.8%	144.6%	125.0%	40.8%	N/A	N/A	N/A
FY 2007 Dec 31, 2007	-96.6%	38.1%	85.0%	-29.5%	N/A	N/A	N/A	N/A
FY 2006 Dec 31, 2006	5488.8%	1261.5%	504.1%	52.6%	N/A	N/A	N/A	N/A
FY 2005 Dec 31, 2005	231.7%	98.6%	-55.0%	N/A	N/A	N/A	N/A	N/A
FY 2004 Dec 31, 2004	18.9%	-83.4%	-64.5%	N/A	N/A	N/A	N/A	N/A
FY 2003 Dec 31, 2003	-97.7%	-80.6%	N/A	-11.9%	N/A	N/A	N/A	N/A
FY 2002 Dec 31, 2002	62.2%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2001 Dec 31, 2001	N/A	N/A	142.2%	N/A	N/A	N/A	N/A	N/A
FY 2000 Dec 31, 2000	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 1999 Dec 31, 1999	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 1998 Dec 31, 1998	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Growth Analysis - ANIP

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on ANI Pharmaceuticals, Inc.

Compare with peers

Explore

Growth Analysis - ANIP

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on ANI Pharmaceuticals, Inc.

Compare with peers

Explore